CYRX
Cryoport·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 3
Bearish signal 2
Consensus Rating "Strong Buy"
Ample Liquidity
Significant Net Income Decline
EPS Beats Expectation
Revenue Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About CYRX
Cryoport, Inc.
A global leader in temperature-controlled supply chain solutions for the life sciences industry supporting life-saving cell and gene therapies across the clinical and commercial spectrum
Healthcare Equipment and Supplies
05/25/1990
07/23/2015
NASDAQ Stock Exchange
1,090
12-31
Common stock
112 Westwood Place, Suite 350, Brentwood, TN 37027
--
Cryoport, Inc., originally incorporated in Nevada on May 25, 1990 under the name GT5- Limited (GT5), changed its name to Cryoport Corporation on March 15, 2005. The company is a global leader in cell and gene therapy supply chain solutions that enable manufacturers, contract manufacturers (CDMOs), contract research organizations (CROs), developers and researchers to carry out their respective businesses. The company provides a wide range of supply chain solutions for the life science industry. Through the company platform of key products and solutions including advanced temperature-controlled packaging, informatics, specialized bio-logistics services, bio-storage, bio-services and cryogenic systems, the company is "Enabling the Future of MedicineTM" to achieve superior supply chain management through the company's innovative systems, compliant procedures and agile approach on a global scale.
Earnings Call
Q1/2025
Estimate EPS-0.26
Actual EPS-0.28
Estimate Revenue42.42M
Actual Revenue41.04M
Cryoport's Q1 2025: Unpacking Contradictions in Service Margins, Revenue Growth, and Market Strategies
May 08,2025 07:33
Earnings Decrypt
Earnings Decrypt
Q2/2025
Estimate EPS-0.22
Actual EPS2.05
Estimate Revenue41.73M
Actual Revenue45.50M
Cryoport's Q2 2025 Earnings Call: Unraveling Key Contradictions in Revenue, Growth, and Profitability Expectations
Aug 05,2025 08:18
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
CYRX has released its 2025 Q3 earnings. EPS was reported at -0.18, versus the expected -0.19, beating expectations. The chart below visualizes how CYRX has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
CYRX has released its 2025 Q3 earnings report, with revenue of 44.23M, reflecting a YoY change of 15.44%, and net profit of -6.94M, showing a YoY change of -962.48%. The Sankey diagram below clearly presents CYRX's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
